A dose-finding study of a potential new painkiller derived from the cannabinoid group has led to the death of one volunteer. The report published in the New England Journal of Medicine is reminiscent of the highly publicised trial of TGN1412, that caused six male volunteers in London to experience a ‘cytokine storm’ with devastating consequences. ...
Another first-in-human painkiller trial ends in death
By Nicola Garrett
9 Nov 2016